Quest Diagnostics (NY: DGX )

149.91 -0.86 (-0.57%)

Streaming Delayed Price Updated: 12:22 PM EDT, Aug 14, 2024 Add to My Watchlist

Price and Volume

Volume	117,189
Open	150.47
Bid (Size)	149.88 (2)
Ask (Size)	150.05 (4)
Prev. Close	150.77
Today's Range	149.44 - 150.74
52wk Range	119.59 - 152.00
Shares Outstanding	122,180,759
Dividend Yield	1.89%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

8 Health Care Stocks With Whale Alerts In Today's Session

August 01, 2024

Via Benzinga

LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector

August 01, 2024

LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024...

Via Benzinga

Performance

YTD	+6.46%	+6.46%
1 Month	+3.68%	+3.68%
3 Month	+7.73%	+7.73%
6 Month	+17.25%	+17.25%
1 Year	+10.92%	+10.92%

More News

Uncovering Dividend Opportunities with NYSE:DGX.

July 25, 2024

Via Chartmill

5 Analysts Assess Quest Diagnostics: What You Need To Know

July 24, 2024

Via Benzinga

Quest Diagnostics' Q2 Earnings Performance Suggests Stable Stock, Modest Growth Ahead, Analyst Says

July 23, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics

July 05, 2024

Via Benzinga

How Is The Market Feeling About Quest Diagnostics?

June 27, 2024

Via Benzinga

Peering Into Quest Diagnostics's Recent Short Interest

June 10, 2024

Via Benzinga

Analyst Scoreboard: 7 Ratings For Quest Diagnostics

May 30, 2024

Via Benzinga

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?

July 23, 2024

Via Benzinga

DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q2 2024

July 23, 2024

Via InvestorPlace

US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist

July 23, 2024

Via Benzinga

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally

July 21, 2024

Via Benzinga

How Is The Market Feeling About Quest Diagnostics?

May 24, 2024

Via Benzinga

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

April 29, 2024

Via Benzinga

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

July 18, 2024

From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology

Via GlobeNewswire

EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy

July 18, 2024

Via Benzinga

S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday

July 05, 2024

Via Benzinga

Peering Into Quest Diagnostics's Recent Short Interest

April 24, 2024

Via Benzinga

The Analyst Landscape: 5 Takes On Quest Diagnostics

April 24, 2024

Via Benzinga

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests

June 18, 2024

Via MarketBeat

Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High

May 15, 2024

Via Benzinga

Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX

April 30, 2024

Via AB Newswire

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth

April 25, 2024

Via Talk Markets

Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic

April 23, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.